Drug's journey in the body: first tests begin
NCT ID NCT07466550
Summary
This early-stage study aims to understand how the drug risankizumab moves through and is processed by the body. It will compare two ways of giving the drug: as an injection under the skin and as an infusion into a vein. The study will enroll 60 healthy volunteers to measure drug levels and check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.